Global Point of Care Molecular Diagnostics Market size was USD 4.8 billion in 2024 and is projected to reach USD 11.2 billion by 2033, with a CAGR of 9.8% during the forecast period.
The global point of care molecular diagnostics market is experiencing robust growth, driven by increasing demand for rapid and accurate testing, rising prevalence of infectious diseases and chronic conditions, and advancements in portable and user-friendly diagnostic technologies. Point of care molecular diagnostics, available in assays & kits, instruments & analyzers, and software & services, are valued for their quick results, decentralization of testing, and support for immediate clinical decisions in applications like respiratory diseases, sexually transmitted diseases, and cancer detection. From 2021 to 2023, the market expanded due to heightened focus on infectious disease testing post-pandemic, growth in telemedicine integrations, and innovations in RT-PCR and INAAT for high sensitivity. Key trends include the dominance of assays & kits for their convenience, the prominence of RT-PCR technology for precision, and the rise of respiratory diseases applications for pandemic preparedness. North America holds the largest market share, led by the United States due to its advanced healthcare infrastructure and R&D investments. Asia Pacific is the fastest-growing region, fueled by increasing healthcare access and disease burdens in India. Challenges such as high device costs, regulatory approvals for new tests, and training needs for non-lab settings persist, but opportunities in AI integrations and emerging markets drive growth through 2033. Debates over accuracy in decentralized testing and accessibility highlight the need for reliable solutions, with empathy for manufacturers balancing innovation and regulatory compliance.
Research Objective
MARKET SEGMENTATION
Scope of the Study
Key Questions Answered in the Report
Chapter 1 Research Methodology
1.1 Research Objective
1.2 Market Research Process
1.2.1 Data Procurement and Data Mining
1.2.2 Data Analysis and Standardization
1.2.3 Data Processing and Market Formulation
1.2.4 Data Validation
1.3 Market Research Approach
1.3.1 Residential Research
1.3.2 Commercial Research
1.3.3 Assumptions & Limitations
1.4 Year Considered for the Study
Chapter 2 Executive Summary
2.1 Global Point of Care Molecular Diagnostics Market Snapshot
2.2 Global Point of Care Molecular Diagnostics Market
Chapter 3 Market Variables and Scope
3.1 Introduction to Point of Care Molecular Diagnostics
3.2 Classification and Scope
Chapter 4 Market Dynamics and Trends
4.1 Global Point of Care Molecular Diagnostics Market Dynamics
4.2 Global Point of Care Molecular Diagnostics Market Dynamics, Impact Analysis
4.3 Market Drivers
4.3.1 Driver 1
4.3.2 Driver 2
4.4 Market Restraints
4.4.1 Restraint 1
4.4.2 Restraint 2
4.5 Market Opportunity
4.5.1 Opportunity 1
4.5.2 Opportunity 2
Chapter 5 Premium Insights
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of Substitute Types
5.1.4 Rivalry among Existing Firms
5.1.5 Threat of New Entrants
5.2 Supply Chain Analysis
5.3 Market Share Analysis of Key Players, 2024
5.4 Market Entry Strategy Assessment
5.5 Strategic Recommendation for Stakeholders
Chapter 6 Global Point of Care Molecular Diagnostics Market, By Product Type
6.1 Global Point of Care Molecular Diagnostics Market, By Product Type, 2025 - 2033
6.2 Assays & Kits
6.3 Instruments & Analyzers
6.4 Software & Services
Chapter 7 Global Point of Care Molecular Diagnostics Market, By Technology
7.1 Global Point of Care Molecular Diagnostics Market, By Technology, 2025 - 2033
7.2 RT-PCR
7.3 INAAT
7.4 Other Technologies
Chapter 8 Global Point of Care Molecular Diagnostics Market, By Application
8.1 Global Point of Care Molecular Diagnostics Market, By Application, 2025 - 2033
8.2 Respiratory Diseases
8.3 Sexually Transmitted Diseases
8.4 Hospital-acquired Infections
8.5 Cancer
8.6 Hepatitis
8.7 Gastrointestinal Disorders
8.8 Other Applications
Chapter 9 Global Point of Care Molecular Diagnostics Market, By Sample Type
9.1 Global Point of Care Molecular Diagnostics Market, By Sample Type, 2025 - 2033
9.2 Blood, Serum & Plasma
9.3 Urine
9.4 Other Sample Types
Chapter 10 Global Point of Care Molecular Diagnostics Market, By End-Use
10.1 Global Point of Care Molecular Diagnostics Market, By End-Use, 2025 - 2033
10.2 Hospitals & ICUs
10.3 Physicians Offices
10.4 Diagnostic Laboratories
10.5 Research Institutes
10.6 Other End Users
Chapter 11 Global Point of Care Molecular Diagnostics Market, By Region
11.1 Overview
11.2 North America
11.2.1 North America Point of Care Molecular Diagnostics Market, By Country
11.2.2 North America Point of Care Molecular Diagnostics Market, By Product Type
11.2.3 North America Point of Care Molecular Diagnostics Market, By Technology
11.2.4 North America Point of Care Molecular Diagnostics Market, By Application
11.2.5 North America Point of Care Molecular Diagnostics Market, By Sample Type
11.2.6 North America Point of Care Molecular Diagnostics Market, By End-Use
11.2.7 United States
11.2.7.1 United States Point of Care Molecular Diagnostics Market, By Product Type
11.2.7.2 United States Point of Care Molecular Diagnostics Market, By Technology
11.2.7.3 United States Point of Care Molecular Diagnostics Market, By Application
11.2.7.4 United States Point of Care Molecular Diagnostics Market, By Sample Type
11.2.7.5 United States Point of Care Molecular Diagnostics Market, By End-Use
11.2.8 Canada
11.2.8.1 Canada Point of Care Molecular Diagnostics Market, By Product Type
11.2.8.2 Canada Point of Care Molecular Diagnostics Market, By Technology
11.2.8.3 Canada Point of Care Molecular Diagnostics Market, By Application
11.2.8.4 Canada Point of Care Molecular Diagnostics Market, By Sample Type
11.2.8.5 Canada Point of Care Molecular Diagnostics Market, By End-Use
11.2.9 Others
11.2.9.1 Others Point of Care Molecular Diagnostics Market, By Product Type
11.2.9.2 Others Point of Care Molecular Diagnostics Market, By Technology
11.2.9.3 Others Point of Care Molecular Diagnostics Market, By Application
11.2.9.4 Others Point of Care Molecular Diagnostics Market, By Sample Type
11.2.9.5 Others Point of Care Molecular Diagnostics Market, By End-Use
11.3 Europe
11.3.1 Europe Point of Care Molecular Diagnostics Market, By Country
11.3.2 Europe Point of Care Molecular Diagnostics Market, By Product Type
11.3.3 Europe Point of Care Molecular Diagnostics Market, By Technology
11.3.4 Europe Point of Care Molecular Diagnostics Market, By Application
11.3.5 Europe Point of Care Molecular Diagnostics Market, By Sample Type
11.3.6 Europe Point of Care Molecular Diagnostics Market, By End-Use
11.3.7 United Kingdom
11.3.7.1 United Kingdom Point of Care Molecular Diagnostics Market, By Product Type
11.3.7.2 United Kingdom Point of Care Molecular Diagnostics Market, By Technology
11.3.7.3 United Kingdom Point of Care Molecular Diagnostics Market, By Application
11.3.7.4 United Kingdom Point of Care Molecular Diagnostics Market, By Sample Type
11.3.7.5 United Kingdom Point of Care Molecular Diagnostics Market, By End-Use
11.3.8 Germany
11.3.8.1 Germany Point of Care Molecular Diagnostics Market, By Product Type
11.3.8.2 Germany Point of Care Molecular Diagnostics Market, By Technology
11.3.8.3 Germany Point of Care Molecular Diagnostics Market, By Application
11.3.8.4 Germany Point of Care Molecular Diagnostics Market, By Sample Type
11.3.8.5 Germany Point of Care Molecular Diagnostics Market, By End-Use
11.3.9 France
11.3.9.1 France Point of Care Molecular Diagnostics Market, By Product Type
11.3.9.2 France Point of Care Molecular Diagnostics Market, By Technology
11.3.9.3 France Point of Care Molecular Diagnostics Market, By Application
11.3.9.4 France Point of Care Molecular Diagnostics Market, By Sample Type
11.3.9.5 France Point of Care Molecular Diagnostics Market, By End-Use
11.3.10 Italy
11.3.10.1 Italy Point of Care Molecular Diagnostics Market, By Product Type
11.3.10.2 Italy Point of Care Molecular Diagnostics Market, By Technology
11.3.10.3 Italy Point of Care Molecular Diagnostics Market, By Application
11.3.10.4 Italy Point of Care Molecular Diagnostics Market, By Sample Type
11.3.10.5 Italy Point of Care Molecular Diagnostics Market, By End-Use
11.3.11 Spain
11.3.11.1 Spain Point of Care Molecular Diagnostics Market, By Product Type
11.3.11.2 Spain Point of Care Molecular Diagnostics Market, By Technology
11.3.11.3 Spain Point of Care Molecular Diagnostics Market, By Application
11.3.11.4 Spain Point of Care Molecular Diagnostics Market, By Sample Type
11.3.11.5 Spain Point of Care Molecular Diagnostics Market, By End-Use
11.3.12 Others
11.3.12.1 Others Point of Care Molecular Diagnostics Market, By Product Type
11.3.12.2 Others Point of Care Molecular Diagnostics Market, By Technology
11.3.12.3 Others Point of Care Molecular Diagnostics Market, By Application
11.3.12.4 Others Point of Care Molecular Diagnostics Market, By Sample Type
11.3.12.5 Others Point of Care Molecular Diagnostics Market, By End-Use
11.4 Asia Pacific
11.4.1 Asia Pacific Point of Care Molecular Diagnostics Market, By Country
11.4.2 Asia Pacific Point of Care Molecular Diagnostics Market, By Product Type
11.4.3 Asia Pacific Point of Care Molecular Diagnostics Market, By Technology
11.4.4 Asia Pacific Point of Care Molecular Diagnostics Market, By Application
11.4.5 Asia Pacific Point of Care Molecular Diagnostics Market, By Sample Type
11.4.6 Asia Pacific Point of Care Molecular Diagnostics Market, By End-Use
11.4.7 China
11.4.7.1 China Point of Care Molecular Diagnostics Market, By Product Type
11.4.7.2 China Point of Care Molecular Diagnostics Market, By Technology
11.4.7.3 China Point of Care Molecular Diagnostics Market, By Application
11.4.7.4 China Point of Care Molecular Diagnostics Market, By Sample Type
11.4.7.5 China Point of Care Molecular Diagnostics Market, By End-Use
11.4.8 Japan
11.4.8.1 Japan Point of Care Molecular Diagnostics Market, By Product Type
11.4.8.2 Japan Point of Care Molecular Diagnostics Market, By Technology
11.4.8.3 Japan Point of Care Molecular Diagnostics Market, By Application
11.4.8.4 Japan Point of Care Molecular Diagnostics Market, By Sample Type
11.4.8.5 Japan Point of Care Molecular Diagnostics Market, By End-Use
11.4.9 India
11.4.9.1 India Point of Care Molecular Diagnostics Market, By Product Type
11.4.9.2 India Point of Care Molecular Diagnostics Market, By Technology
11.4.9.3 India Point of Care Molecular Diagnostics Market, By Application
11.4.9.4 India Point of Care Molecular Diagnostics Market, By Sample Type
11.4.9.5 India Point of Care Molecular Diagnostics Market, By End-Use
11.4.10 South Korea
11.4.10.1 South Korea Point of Care Molecular Diagnostics Market, By Product Type
11.4.10.2 South Korea Point of Care Molecular Diagnostics Market, By Technology
11.4.10.3 South Korea Point of Care Molecular Diagnostics Market, By Application
11.4.10.4 South Korea Point of Care Molecular Diagnostics Market, By Sample Type
11.4.10.5 South Korea Point of Care Molecular Diagnostics Market, By End-Use
11.4.11 Australia
11.4.11.1 Australia Point of Care Molecular Diagnostics Market, By Product Type
11.4.11.2 Australia Point of Care Molecular Diagnostics Market, By Technology
11.4.11.3 Australia Point of Care Molecular Diagnostics Market, By Application
11.4.11.4 Australia Point of Care Molecular Diagnostics Market, By Sample Type
11.4.11.5 Australia Point of Care Molecular Diagnostics Market, By End-Use
11.4.12 Others
11.4.12.1 Others Point of Care Molecular Diagnostics Market, By Product Type
11.4.12.2 Others Point of Care Molecular Diagnostics Market, By Technology
11.4.12.3 Others Point of Care Molecular Diagnostics Market, By Application
11.4.12.4 Others Point of Care Molecular Diagnostics Market, By Sample Type
11.4.12.5 Others Point of Care Molecular Diagnostics Market, By End-Use
11.5 Latin America
11.5.1 Latin America Point of Care Molecular Diagnostics Market, By Country
11.5.2 Latin America Point of Care Molecular Diagnostics Market, By Product Type
11.5.3 Latin America Point of Care Molecular Diagnostics Market, By Technology
11.5.4 Latin America Point of Care Molecular Diagnostics Market, By Application
11.5.5 Latin America Point of Care Molecular Diagnostics Market, By Sample Type
11.5.6 Latin America Point of Care Molecular Diagnostics Market, By End-Use
11.5.7 Brazil
11.5.7.1 Brazil Point of Care Molecular Diagnostics Market, By Product Type
11.5.7.2 Brazil Point of Care Molecular Diagnostics Market, By Technology
11.5.7.3 Brazil Point of Care Molecular Diagnostics Market, By Application
11.5.7.4 Brazil Point of Care Molecular Diagnostics Market, By Sample Type
11.5.7.5 Brazil Point of Care Molecular Diagnostics Market, By End-Use
11.5.8 Others
11.5.8.1 Others Point of Care Molecular Diagnostics Market, By Product Type
11.5.8.2 Others Point of Care Molecular Diagnostics Market, By Technology
11.5.8.3 Others Point of Care Molecular Diagnostics Market, By Application
11.5.8.4 Others Point of Care Molecular Diagnostics Market, By Sample Type
11.5.8.5 Others Point of Care Molecular Diagnostics Market, By End-Use
11.6 Middle East and Africa (MEA)
11.6.1 Middle East and Africa (MEA) Point of Care Molecular Diagnostics Market, By Country
11.6.2 Middle East and Africa (MEA) Point of Care Molecular Diagnostics Market, By Product Type
11.6.3 Middle East and Africa (MEA) Point of Care Molecular Diagnostics Market, By Technology
11.6.4 Middle East and Africa (MEA) Point of Care Molecular Diagnostics Market, By Application
11.6.5 Middle East and Africa (MEA) Point of Care Molecular Diagnostics Market, By Sample Type
11.6.6 Middle East and Africa (MEA) Point of Care Molecular Diagnostics Market, By End-Use
11.6.7 United Arab Emirates
11.6.7.1 United Arab Emirates Point of Care Molecular Diagnostics Market, By Product Type
11.6.7.2 United Arab Emirates Point of Care Molecular Diagnostics Market, By Technology
11.6.7.3 United Arab Emirates Point of Care Molecular Diagnostics Market, By Application
11.6.7.4 United Arab Emirates Point of Care Molecular Diagnostics Market, By Sample Type
11.6.7.5 United Arab Emirates Point of Care Molecular Diagnostics Market, By End-Use
11.6.8 Others
11.6.8.1 Others Point of Care Molecular Diagnostics Market, By Product Type
11.6.8.2 Others Point of Care Molecular Diagnostics Market, By Technology
11.6.8.3 Others Point of Care Molecular Diagnostics Market, By Application
11.6.8.4 Others Point of Care Molecular Diagnostics Market, By Sample Type
11.6.8.5 Others Point of Care Molecular Diagnostics Market, By End-Use
Chapter 12 Competitive Landscape
12.1 Strategic Move Analysis
12.1.1 Top Player Positioning/Market Share Analysis
12.1.2 Top Winning Strategies, By Year, 2021-2024
12.1.3 Competitive Analysis by Revenue, 2022-2024
12.2 Recent Developments by the Market Participants (2024-25)
Chapter 13 Company Profiles
13.1 Abbott Laboratories
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Performance
13.1.4 Product Portfolio
13.1.5 Strategic Growth
13.2 F. Hoffmann-La Roche Ltd.
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Performance
13.2.4 Product Portfolio
13.2.5 Strategic Growth
13.3 bioMérieux SA
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Performance
13.3.4 Product Portfolio
13.3.5 Strategic Growth
13.4 Becton, Dickinson and Company
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Performance
13.4.4 Product Portfolio
13.4.5 Strategic Growth
13.5 Cepheid (Danaher Corporation)
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Performance
13.5.4 Product Portfolio
13.5.5 Strategic Growth
13.6 Quidel Corporation
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Performance
13.6.4 Product Portfolio
13.6.5 Strategic Growth
13.7 Bio-Rad Laboratories Inc.
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Performance
13.7.4 Product Portfolio
13.7.5 Strategic Growth
13.8 Siemens Healthineers AG
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Performance
13.8.4 Product Portfolio
13.8.5 Strategic Growth
13.9 Thermo Fisher Scientific Inc.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Performance
13.9.4 Product Portfolio
13.9.5 Strategic Growth
13.10 OraSure Technologies Inc.
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Performance
13.10.4 Product Portfolio
13.10.5 Strategic Growth
13.11 iHealth Labs Inc.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Performance
13.11.4 Product Portfolio
13.11.5 Strategic Growth
13.12 Lucira Health Inc.
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Performance
13.12.4 Product Portfolio
13.12.5 Strategic Growth
13.13 Cue Health Inc.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Performance
13.13.4 Product Portfolio
13.13.5 Strategic Growth
13.14 Hologic Inc.
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Performance
13.14.4 Product Portfolio
13.14.5 Strategic Growth
13.15 LumiraDx Ltd.
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Performance
13.15.4 Product Portfolio
13.15.5 Strategic Growth
1. What are point of care molecular diagnostics?
They are rapid, near-patient molecular tests that deliver highly accurate results using technologies like RT-PCR and INAAT without requiring a centralized laboratory.
2. What is driving demand for point of care molecular diagnostics?
Rising infectious disease outbreaks, chronic disease monitoring, and the need for fast decision-making in clinical settings are key growth drivers.
3. Which product type dominates the market?
Assays and kits lead the market because they are easy to use, require minimal training, and support quick diagnostic turnaround.
4. Which region currently leads the market?
North America holds the largest share due to advanced healthcare systems, strong R&D activity, and high adoption of rapid diagnostic technologies.
5. What major challenges does the market face?
High device costs, lengthy regulatory approvals, and operator training requirements can slow adoption, especially in smaller or resource-limited facilities.
You can conveniently pay for your desired report through the following payment options:
Upon completing the payment process, a detailed invoice will be promptly sent to your email address. This email will serve as your official receipt for the purchased report. If you encounter any issues or require additional assistance, feel free to reach out to our team, and we’ll be happy to help.
Our reports are accessible in various formats tailored to your needs:
Absolutely! You have the option to purchase individual sections of the report. Simply reach out to our dedicated sales representative, and they will assist you with your request. Feel free to contact our sales team, and they will guide you through the process of obtaining specific sections tailored to your needs.
n adherence to industry standards, all sales are considered final, and payments made are non-refundable. This policy aligns with the unique nature of our business, where a report constitutes a transfer of our market knowledge and understanding.
However, recognizing the importance of client satisfaction, we provide robust post-sales support, including:
$3,499.00
Precise View Reports delivers accurate market insights and tailored industry reports to empower businesses in making informed strategic decisions.
Copyright @2026, All Rights Reserved.